Comparison of Two Phase II Trials of Neoadjuvant Temozolomide Followed with Concomitant and Adjuvant Temozolomide and Hypofractionated Accelerated Radiotherapy with or without Metformin in Patients with Newly Diagnosed Glioblastoma

被引：0
|
作者：
Shenouda, G. [1 ]
Petrecca, K. [2 ]
Abdulkarim, B. S. [3 ]
Owen, S. [1 ]
Panet-Raymond, V. [3 ]
Diaz, R. [4 ]
Guiot, M. C. [5 ]
Carvalho, T. [6 ]
Charbonneau, M. [1 ]
Hall, J. [7 ]
Souhami, L.
机构：
[1] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
[2] McGill Univ, Neurosurg, Montreal, PQ, Canada
[3] McGill Univ, Ctr Hlth, Dept Radiat Oncol, Montreal, PQ, Canada
[4] Montreal Neurol Hosp, Montreal, PQ, Canada
[5] Montreal Neurol Inst Hosp, Dept Pathol, Montreal, PQ, Canada
[6] McGill Univ, Montreal, PQ, Canada
[7] Montreal Neurol Hosp, Montreal, PQ, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
211
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 50 条
  • [21] POSTOPERATIVE HYPOFRACTIONATED ACCELERATED INTENSITY MODULATED RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN THE MANAGEMENT OF PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: RESULTS OF A PILOT STUDY
    Biswas, A.
    Julka, P. K.
    Sharma, S.
    Binjola, A.
    Laviraj, M. A.
    Sarkar, C.
    Rath, G. K.
    NEURO-ONCOLOGY, 2016, 18 : 42 - 42
  • [22] PHASE I/II TRIAL OF RADIATION THERAPY, TEMOZOLOMIDE AND PEMBROLIZUMAB FOLLOWED BY TEMOZOLOMIDE AND PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Dixit, Karan
    Kumthekar, Priya
    Kruser, Timothy
    Bloch, Orin
    Chandler, James
    Tate, Matthew
    Raizer, Jeffrey
    NEURO-ONCOLOGY, 2016, 18 : 19 - 19
  • [23] Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations
    Chinot, OL
    Barrie, M
    Frauger, E
    Dufour, H
    Figarella-Branger, D
    Palmari, J
    Braguer, D
    Hoang-Xuan, K
    Moktari, K
    Peragut, JCC
    Martin, PMM
    Grisoli, F
    CANCER, 2004, 100 (10) : 2208 - 2214
  • [24] Phase II - Study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations
    Alliot, C
    CANCER, 2004, 101 (12) : 2897 - 2898
  • [25] Hypofractionated accelerated radiotherapy (HART) with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM)
    Mallick, Supriya
    Haresh, K. P.
    Gupta, Subhash
    Sharma, Seema
    Laviraj, M. A.
    Upadhyay, Ashish Dutt
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] TO EVALUATE THE OUTCOMES OF CONCOMITANT CHEMORADIOTHERAPY FOLLOWED BY EXTENDED ADJUVANT TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA - A RETROSPECTIVE STUDY
    Gupta, S.
    Gupta, S. K.
    Mathur, R.
    VALUE IN HEALTH, 2016, 19 (07) : A849 - A849
  • [27] OUTCOMES AND PREDICTORS OF SURVIVAL FOLLOWING CONCOMITANT AND ADJUVANT TEMOZOLOMIDE WITH RADIOTHERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Swaminath, A.
    McMillan, W.
    McCarter, H.
    Hirte, H.
    Whitton, A.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S52 - S52
  • [28] Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study
    Hofland, Kenneth F.
    Hansen, Steinbjorn
    Sorensen, Morten
    Engelholm, Silke
    Schultz, Henrik P.
    Muhic, Aida
    Grunnet, Kirsten
    Ask, Anders
    Costa, Junia C.
    Kristiansen, Charlotte
    Thomsen, Carsten
    Poulsen, Hans Skovgaard
    Lassen, Ulrik
    ACTA ONCOLOGICA, 2014, 53 (07) : 939 - 944
  • [29] A Phase II Trial of Concurrent Sunitinib, Temozolomide and Radiation Therapy Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients with an Unmethylated MGMT Gene Promoter
    Faye, M. D.
    Sabri, S.
    De Robles, P.
    Agnihotram, R.
    Torres-Vasquez, A.
    Panet-Raymond, V.
    Shenouda, G.
    Souhami, L.
    Esaw, J.
    Abdulkarim, B. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S169 - S169
  • [30] Hypofractionated Accelerated Radiotherapy With Concurrent And Maintenance Temozolomide In Newly Diagnosed Glioblastoma- Updated Results Of A Phase 2 Trial
    Rath, G. K.
    Mallick, S.
    Kunhiparambath, H.
    Gupta, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E702 - E703
12345